Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for untreatable cancers.
Axiom Therapeutics has raised $12.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2026.
Axiom Therapeutics's investors include Plug and Play, Verve Ventures, Panacea Capital.
Axiom Therapeutics is headquartered in London, United Kingdom.
Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for untreatable cancers.
Axiom Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axiom Therapeutics — Funding & Investors." VCBacked, August 25, 2026, https://www.vcbacked.co/company/axiom-therapeutics. Accessed October 17, 2026.
VCBacked. (2026). Axiom Therapeutics — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/axiom-therapeutics
{{cite web |title=Axiom Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/axiom-therapeutics |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated